Stay updated with breaking news from Active Implants. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Global Healthcare Nanotechnology Market Report by The Business Research Company covers the market drivers, size, major players, and the impact of COVID-19
By 2030, total knee replacements in the US are expected to increase by more than 180%...
Orthopedics Today | Innovation is required in areas of unmet clinical need, and this can be no truer than in the symptomatic post-meniscectomized knee.While many patients have improvements after meniscectomy, resection can alter joint biomechanics and overload articular cartilage. Long-term, 50% of meniscectomized patients develop symptomatic osteoarthritis due to increased contact pressures, which then leads to
Meniscus Implant Relieves Pain in as Early as 6 Months Two-year results from the MERCURY study suggests that the NUsurface Meniscus Implant provides statistically superior pain relief beginning at 6 months compared to non-surgical therapy, Active Implants LLC reports. The results were presented at the American Orthopedic Society for Sports Medicine-Arthroscopy Association of North America Combined 2021 Annual Meeting in Nashville. The NUsurface Implant is currently being marketed in Europe. However, it is currently under review by the US Food & Drug Administration (FDA). Breakthrough D...
E-Mail The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing eleven new Collaborative Research Centres (CRC) to promote world-class research at universities. This was announced by the relevant Grants Committee, which met by video conference due to the coronavirus pandemic. The new CRCs will initially receive a total of approximately €138 million over a period of four years from 1 July 2021 onwards. This includes a 22-percent programme allowance for indirect project-related costs. Seven of the new consortia are CRC/Transregios (TRR) distributed across multip...